1 The aim of this study was to determine whether dierent signal transduction mechanisms underlie the Ca 2+ sensitizing eects of guanosine 5'-O-(3-thiotriphosphate) (GTP g S) and receptor agonists on b-escin-skinned smooth muscle of rabbit mesenteric artery. 2 In the homogenate of the b-escin-skinned arterial strip, C3 exoenzyme of Clostridium botulinum catalyzed the [ 32 P]-ADP-ribosylation of only one protein that had the same molecular mass as the protein detected in Western blots with anti-rho p21 antibody. Pretreatment of preparations with C3 resulted in great inhibition of GTP g S-induced Ca 2+ sensitization, although the eect of GTP g S at higher concentrations (530 mM) was not completely blocked by this treatment. In contrast, the enhancement by phenylephrine and histamine, in the presence of guanosine 5'-triphosphate, of the Ca sensitizing eects of phenylephrine and histamine were also blocked by these tyrosine kinase inhibitors. 5 These results suggest that rho p21 predominantly mediates GTP g S-induced Ca 2+ sensitization of b-escin-skinned smooth muscle of rabbit mesenteric artery, while the Ca 2+ sensitizing actions of heterotrimeric G protein-coupled receptor agonists do not involve this small G protein. However, it seems that tyrosine phosphorylation, but not PKC activation, plays an important role in both of the rho p21 protein-and heterotrimeric G protein-mediated Ca 2+ sensitization mechanisms.
Introduction
Smooth muscle contraction is primarily regulated by phosphorylation of the 20 kDa myosin light chain (MLC 20 ) (Hartshorne, 1987) . MLC 20 is speci®cally phosphorylated by the Ca 2+ /calmodulin-dependent MLC 20 kinase, which then activates actomyosin ATPase (Hartshorne, 1987) . Thus, the greater tension development is associated with an increase in MLC 20 phosphorylation (Rembold & Murphy, 1988; Hori et al., 1992) , and a rise in cytosolic Ca 2+ increases the MLC 20 kinase/phosphatase activity ratio by activation of the kinase (Hartshorne, 1987; Kamm & Stull, 1989) . However, the cytosolic Ca 2+ level is not always parallel with the contraction level (Bradley & Morgan, 1987) . Indeed, receptor agonists cause greater contraction than high K + -depolarization at a given cytosolic Ca 2+ level (Karaki, 1989; Somlyo & Himpens, 1989) . In smooth muscle permeabilized with bacterial a-toxin, receptor agonists have been found to lower the Ca 2+ concentrations necessary for the contraction, suggesting that the agonists enhance Ca 2+ sensitivity of contractile apparatus (`Ca 2+ sensitization') (Nishimura et al., 1988; Kitazawa et al., 1989) . Because receptor agonists stimulate the hydrolysis of phosphatidylinositol 4,5-bisphosphate through activation of phospholipase C and result in diacylglycerol as well as inositol 1,4,5-trisphosphate, and diacylglycerol activates protein kinase C (PKC) (Nishizuka, 1986) , and because phorbol esters that activate PKC also enhance the Ca 2+ sensitivity of myo®laments in permeabilized smooth muscle preparations (Chatterjee & Tejada, 1986; Fujiwara et al., 1988; Nishimura & van Breemen, 1989; Itoh et al., 1994) , it has been suggested that PKC plays a role in agonist-induced Ca 2+ sensitization (Lee & Severson, 1994) . Guanosine 5'-triphosphate (GTP) or guanosine 5'-O-(3-thiotriphosphate) (GTP g S) can mimic the Ca 2+ sensitizing eects of receptor agonists (Nishimura et al., 1988; Fujiwara et al., 1988; Kitazawa et al., 1989) . Recently, it has been shown that GTP g S-induced Ca 2+ sensitization is inhibited by pretreatment with C3 exoenzyme from Clostridium botulinum, which is known to selectively inactive rho p21, a small G protein , in permeabilized smooth muscle of rabbit mesenteric artery (Hirata et al., 1992) , guinea-pig ileum (Itagaki et al., 1995) , and guinea-pig vas deferens (Fujita et al., 1995) . These ®ndings suggest that rho p21, rather than heterotrimeric G proteins, is involved in GTP g S-induced Ca 2+ sensitization. However, the important question of whether the Ca 2+ sensitizing eects of heterotrimeric G protein-coupled receptor agonists are also regulated by this small G protein remains unresolved. Thus, to address this question, we initially decided to compare the in¯uence of C3 pretreatment on the Ca 2+ sensitizing eects of GTP g S and receptor agonists, phenylephrine and histamine, in b-escin-skinned smooth muscle of rabbit mesenteric artery. If dierent G proteins were involved in GTP g S-and agonist-induced Ca 2+ sensitization, the signalling events for these two Ca 2+ sensitizing actions might dier each other. A number of recent reports have shown that pharmacological inhibitors of tyrosine kinases inhibit contractions by agonists such as angiotensin II and norepinephrine in vascular smooth muscle (Di Salvo et al., 1993; Hollenberg, 1994; Filipeanu et al., 1995; Jinsi et al., 1996) , suggesting that tyrosine phosphorylation, rather than PKC activation, may be a key signalling event for Ca 2+ sensitization of contractile apparatus during agonist-induced contractile activation of vascular smooth muscle. Therefore, the goal of this study was to ask the question what plays a signaling role in each of GTP g S-and agonist-induced Ca 2+ sensitization of contractile apparatus of vascular smooth muscle. For this purpose, we assessed the contribution of PKC and tyrosine kinases to the actions of GTP g S and receptor agonists on Ca
2+
-induced contractions in rabbit arterial skinned muscle using a pharmacological approach with the respective relatively selective inhibitors.
Methods

Preparation and tension measurement
Male New Zealand White rabbits, weighing 2 ± 2.5 kg, were anaesthetized with pentobarbitone sodium (35 mg kg 71 , i.v.) and then exsanguinated. The mesenteric artery of the ileum region (diameter around 1 mm) was removed immediately and placed in oxygenated physiological salt solution at room temperature. The solution contained (mM) NaCl 130, KCl 4, CaCl 2 1.5, MgCl 2 1.0, Tris-HCl 10 (pH 7.4) and glucose 10. The artery was cleaned of adhering fat and connective tissue under a dissection microscope. Endothelial cells were removed by gentle rubbing of the intimal surface of the artery with a razor blade. A small bundle of muscle ®bres (1.5 ± 2.0 mm length, 0.4 ± 0.5 mm width) were tied with mono®lament silk to the ®re tips of two tungsten needles, one of which was connected to a force transducer (TB 651-T, Nihon Kohden). The preparation was immersed in one of wells (0.75 ml volume each) engraved in a plastic plate. The bundles were stretched to about 1.2 times their resting length. Solutions were rapidly changed by sliding the plate to an adjacent well. The skinning of bundles was achieved using b-escin. The methods used for skinning and the composition of the solutions have been described elsewhere (Tomita et al., 1997) . Brie¯y, the preparations were treated with 50 mM b-escin (Sigma) for 30 min in a relaxing solution. The composition of the relaxing solution was: 87 mM potassium methanesulphonate, 20 mM PIPES, 5.1 mM Mg(methanesulphonate) 2 , 4.2 mM ATP, 10 mM phosphocreatine, 0.5 mg ml 71 creatine phosphokinase and 10 mM EGTA; the solution was set to pH 7.0 with KOH. After the skinning procedure, the preparations were washed several times to remove b-escin by replacing the normal relaxing solution.
To 
ADP-ribosylation of proteins with C3 exoenzyme
Some skinned muscle strips were incubated with 1 mg ml 71 C3 exoenzyme for 30 min at room temperature in relaxing solution containing 10 mM nicotinamide adenine dinucleotide (NAD). Native and recombinant C3 exoenzymes, which were originated from Clostridium botulinum type D strains South African and from Escherichia coli containing the C3 gene, respectively, as previously described (Moriishi et al., 1991 (Moriishi et al., , 1993 , were used. After the incubation, the strips were washed several times with the relaxing solution. As control preparations, the strips incubated without C3 but otherwise handled in the same manner as the C3-treated preparations were used.
The strips were placed in 100 mM Tris-HCl (pH 7.6) containing 1 mM EGTA and 0.5 mM dithiothreitol and ground manually with a micro homogenizer (NS-310E, Nition). Homogenates (50 mg of protein) were added to 200 ml of reaction mixture containing 100 mM Tris-HCl (pH 7.6), 10 mM [a- , New England Nuclear), 10 mM thymidine and 1 mg ml 71 C3. After incubation for 60 min at room temperature, the reactions were stopped by adding 22 ml of 100% (w/v) trichloroacetic acid, and the mixtures were centrifuged at 3,0006g for 5 min. The resulting pellets were washed three times with ether to remove trichloroacetic acid, and then solubilized in sodium dodecyl sulphate (SDS) solution containing 50 mM Tris-HCl (pH 6.8), 2% SDS, 10% glycerol, 0.5 mM dithiothreitol, 5% 2-mercaptoethanol and 0.05% bromophenol blue. The solubilized proteins were subjected to SDS ± PAGE using a 12.5% polyacrylamide gel followed by autoradiography.
Immunoblotting with anti-rho protein antibody
The skinned muscle strips pretreated with or without C3 in the presence of NAD were placed in lysis buer containing 20 mM HEPES (pH 7.4), 150 mM NaCl, 2.5 mM ethylenediaminetetraacetic acid, 50 mM NaF, 10 mM sodium pyrophosphate, 1 mM sodium orthovanadate, 1% sodium deoxycholate, 1 mM phenylmethylsulphonyl¯uoride, 1% Triton X-100, 0.1% SDS, 10% glycerol and 10 mg ml 71 aprotinin on ice for 30 min. Lysates were then homogenized and centrifuged at 6,0006g for 20 min to pellet any insoluble material. The protein concentration of the supernatant was determined by the method of Bradford (1976) . Samples (20 mg) run on SDS ± PAGE using a 12.5% polyacrylamide gel, and electrotransferred to polyvinylidine di¯uoride ®lter (PVDF) membrane. To reduce non-speci®c binding, the PVDF was blocked for 30 min at room temperature in Tris-buered saline (TBS: 20 mM Tris-HCl, 500 mM NaCl, pH 7.5) containing 3% gelatin. Thereafter, the PVDF was washed for 5 min three times in TBS-Tween buer (TTBS: 20 mM Tris-HCl, 500 mM NaCl, 0.05% Tween 20, pH 7.5) and incubated overnight with mouse monoclonal anti-rho A antibody (Santa Cruz Biotechnology) at 1 : 1,000 dilution in TTBS containing 1% gelatin. After extensive washing with TTBS, the PVDF was incubated with horseradish peroxidase conjugated anti-mouse antibody (Bio-Rad) diluted at 1 : 3,000 in TTBS containing 1% gelatin at room temperature for 120 min. Then, the PVDF was washed for 5 min twice in TTBS and washed for 5 min in TBS. The blots were visualized using the enhanced chemiluminescence method according to the manufacturer's (Bio-Rad) instructions.
Drugs
GTP g S, guanosine 5'-O-(2-thiodiphosphate) (GDP b S), calphostin C, staurosporine, phorbol 12,13-dibutyrate (PDBu), genistein, daidzein, l-phenylephrine hydrochloride were purchased from Sigma Chemical Co. Tyrphostin 25 was purchased from Calbiochem, and histamine dihydrochloride was from Merck Research Laboratories. All materials for SDS ± gel electrophoresis were obtained from Bio-Rad Laboratories or Wako Pure Chemical Industries. Other chemicals used in this study were of the highest purity available from Sigma or Wako.
Statistical analysis
All values are presented in terms of the means+s.e.mean. Student's paired t-test or two way analysis of variance (ANOVA) followed by ScheeÂ 's multiple comparison test was used to test the signi®cance of dierences between dierent series. A P value 50.05 was considered statistically signi®cant.
Results
In¯uence of pretreatment with C3 exoenzyme
In the homogenate of the rabbit mesenteric arterial strip permeablized with b-escin, C3 exoenzyme catalyzed the [ 32 P]-ADP-ribosylation of the substrate which was detected as a single band corresponding to a 23-kDa protein on autoradiograph ( Figure 1a ). This ADP-ribosylated protein is most likely to be rho p21, because Western blots of the homogenate with anti-rho p21 antibody showed a band at about 23-kDa that overlayed the band on autoradiograph (Figure 1b) . Pretreatment of the b-escin-permeabilized strip with 1 mg ml 71 C3 in the presence of 10 mM NAD for 30 min eliminated the level of C3-catalyzed [ The permeabilized strip preparation was incubated with or without 1 mg ml 71 C3 and 10 mM NAD for 30 min in the relaxing solution. After homogenization, the samples were incubated with [ 32 P]-NAD in the absence or presence of C3, subjected to SDS ± PAGE and autoradiography as described in Methods. A single substrate for C3 was identi®ed: Mr=23,000. Note that pretreatment of the strip with C3 induced an identical reduction in the amount of substrate available for subsequent in vitro ADPribosylation. (b) The strip homogenate was resolved by SDS ± PAGE, transferred to PVDF, and incubated with anti-rho p21 antibody. Then, blots were processed with anti-rabbit horseradish peroxidase-labelled antibody as described in Methods. The antirho p21 antibody identi®ed one single protein band with a molecular mass of 23 kDa, regardless of whether the strip was pretreated with C3.
Ca
2+ sensitization mechanisms in vascular smooth musclesensitizing eects elicited by GTP g S at higher concentrations (30 and 100 mM) were not completely eliminated by this treatment.
As shown in Figure 3a , GTP (10 mM), when applied during the tension development induced by 0.3 mM Ca 2+ , produced an additional small increase in tension. Subsequent application of 1 mM phenylephrine or 10 mM histamine caused further contraction. Phenylephrine and histamine increased the amplitude of contraction by 47+3% (n=3) and 42+5% (n=4) of maximal force at pCa 4.5, The preparations were ®rst contracted at pCa 6.5. After steady-state contraction developed, 10 mM GTP was applied. Then, when GTP-induced contraction became constant, 1 mM phenylephrine (upper trace) or 10 mM histamine (lower trace) was applied. (b) The preparations were treated with 1 mg ml 71 C3 in the presence of 10 mM NAD for 30 min. After steady-state contraction was obtained at pCa 6.5, the eect of 1 mM phenylephrine or 10 mM histamine was tested in the simultaneous presence of 10 mM GTP.
2+ sensitization mechanisms in vascular smooth musclerespectively. The extent of the enhancement by these agonists of the Ca 2+ -induced contraction was unaltered by C3 pretreatment (Figure 3b) . Thus, the phenylephrine-and histamine-induced increases in the amplitude of contraction were 39+4% (n=4) and 35+3% (n=4) of maximal Ca 2+ -induced contraction in C3-treated arteries, values which were not signi®cantly dierent from those obtained in untreated arteries. Figure 4 shows the concentration-response curves for the eects of phenylephrine and histamine on the contraction induced by 0.3 mM Ca 2+ in untreated and C3-treated arteries. The Ca 2+ -sensitizing eects of phenylephrine and histamine in C3-treated arteries were virtually identical with those in untreated arteries through a wide range of their concentrations.
In¯uences of PKC inhibitors
The PKC activator PDBu (100 nM) increased the contractile force at pCa 6.5 from 18+3 to 49+4% (n=10) of maximum force at pCa 4.5. The PKC inhibitors calphostin C (1 mM) and staurosporine (20 nM) completely blocked the enhancement by PDBu of the Ca 2+ -induced contraction without aecting the Ca 2+ contraction alone ( Figure 5) . The enhancement by 100 mM GTP g S of the 0.3 mM Ca 2+ -induced contraction was apparently unaected by 1 mM calphostin C (Figure 6a, b) . The Ca 2+ -sensitizing eects of 3 and 100 mM GTP g S were substantially similar in the absence and presence of calphostin C (Figure 8 ). Staurosporine also did not modify the enhancement by GTP g S of the Ca 2+ -induced contraction (Figure 6c ). The addition of 100 mM GTP g S increased the contractile force at pCa 6.5 from 22+2 to 61+3% (n=14) of maximum force at pCa 4.5 in control and from 27+5 to 57+3% (n=4) in the presence of 20 nM staurosporine.
In the presence of 10 mM GTP, 1 mM phenylephrine and 10 mM histamine enhanced the contraction induced by 0.3 mM Ca 2+ regardless of whether 1 mM calphostin C was present (Figure 7) . The Ca 2+ -sensitizing eects of phenylephrine (0.1 and 1 mM) and histamine (1 and 10 mM) in the presence of calphostin C were not signi®cantly dierent from those in its Figure 4 Concentration-response curves for the eects of phenylephrine (a) and histamine (b) on the contraction at pCa 6.5 in bescin-skinned smooth muscle of rabbit mesenteric artery untreated and treated with C3 exoenzyme. All experiments were performed in the presence of 10 mM GTP. Relative tension is expressed as a percentage of the tension obtained at pCa 4.5 in the absence of any drug. Points are the means+s.e.mean of four experiments. 
In¯uences of tyrosine kinase inhibitors
The tyrosine kinase inhibitor genistein (100 mM) irreversibly blocked the enhancement by 100 mM GTP g S of the 0.3 mM Ca 2+ -induced contraction without aecting this Ca 2+ contraction alone (Figure 9a) . Similarly, 100 mM tyrphostin 25, another tyrosine kinase inhibitor, which is structurally dierent from genistein, caused an irreversible block of the GTP g S-induced enhancement of the Ca 2+ contraction ( Figure  9b ). On the other hand, 100 mM daidzein, an inactive analogue of genistein, had little inhibitory eect on GTP g S-induced Ca 2+ sensitization (Figure 9c ). The results of these experiments are summarized in Figure 9d .
Genistein (100 mM) also caused an irreversible and complete inhibition of the phenylephrine-and histamine-induced enhancement of the 0.3 mM Ca 2+ -induced contraction ( Figure  10 ). Similar results were found with 100 mM tyrphostin 25 (data not shown).
Neither genistein nor tyrphostin 25 modi®ed the enhancement by 100 nM PDBu of the 0.3 mM Ca 2+ -induced contraction (data not shown).
Discussion
There are two major superfamilies of G proteins involved in signal transduction; one is a superfamily of heterotrimeric G 
Ca
2+ sensitization mechanisms in vascular smooth muscleproteins serving as transducers for membrane receptors and the other is a superfamily including small G proteins more than 40 members . C3 exoenzyme is known to ADP-ribosylation only the rho p21 family among many small G proteins . In the present study, we con®rmed that C3 apparently ADP-ribosylated only one protein in b-escin-permeabilized smooth muscle of rabbit mesenteric artery, the protein having the same molecular mass as the protein detected in Western blots with anti-rho p21 antibody. We found that pretreatment with C3 signi®cantly inhibited the GTP g S-induced enhancement of the Ca 2+ -induced contractions in this arterial preparation. This result is essentially consistent with the notion reported by Hirata et al. (1992) that activation of rho p21 is involved in the GTP g Sinduced increase in myo®lament Ca 2+ sensitivity in rabbit vascular smooth muscle. However, it should be emphasized as a novel ®nding in this study that C3 pretreatment did not completely suppress Ca 2+ sensitization induced by GTP g S at higher concentrations (530 mM). Since the ®nding that GDP b S caused a complete block of GTP g S-induced Ca 2+ sensitization suggests that G proteins play a role in this sensitization, it is likely that heterotrimeric G proteins could contribute, at least in part, to the increase in myo®lament Ca 2+ sensitivity produced by higher concentrations of GTP g S. Thus, small G proteins such as rho p21 may have a greater intrinsic anity for guanine nucleotide analogues compared to heterotrimeric G proteins. If the Ca 2+ sensitizing eect of higher concentrations of GTP g S is indeed mediated partly by heterotrimeric G proteins, this suggests that stimulation of heterotrimeric G protein-coupled receptors may cause Ca 2+ sensitization through a mechanism independent of activation of rho p21. In support of this suggestion, we found that C3 pretreatment failed to inhibit Ca 2+ sensitization induced by phenylephrine and histamine. Similarly, Gong et al. (1996) have demonstrated that ADP-ribosylation of rho p21 with epidermal cell dierentiation inhibitor (EDIN) does not inhibit phenylephrine-induced Ca 2+ sensitization in b-escin-permeabilized rabbit mesenteric artery, although the Ca 2+ sensitizing eects of carbachol and endothelin could be suppressed by EDIN. However, our ®ndings are in contrast to those of Kokubu et al. (1995) who have found that C3 pretreatment abolishes Ca 2+ sensitization produced by activation of the a 1A -adrenoceptor subtype with norepinephrine or clonidine in b-escin-permeabilized smooth muscle of rabbit aorta. This apparent discrepancy may be due to tissue dierences with respect to whether agonist-induced Ca 2+ sensitization requires activation of rho p21. Alternatively, we cannot exclude the possibilty that dierent G protein-coupled receptor agonists may cause Ca 2+ sensitization through dierent signal transduction pathways. Nevertheless, we interpret the present data to indicate that rho p21 is involved in Ca 2+ sensitization induced by GTP g S, but not that by receptor agonists, in smooth muscle of rabbit mesenteric artery.
The role of PKC in Ca 2+ sensitization is well recognized by the potentiating eects of phorbol esters on the Ca 2+ -induced contractions in permeabilized smooth muscle preparations (Chatterjee & Tejada, 1986; Fujiwara et al., 1988; Nishimura & van Breemen, 1989; Itoh et al., 1994) . It has been believed that Open and dotted bars indicate the contractions obtained at pCa 6.5 before and after application of tyrosine kinase inhibitors, respectively, and hatched bars show the contractions at pCa 6.5 in the presence of 100 mM GTP g S in each case. Relative tension is expressed as a percentage of the tension obtained at pCa 4.5 in the absence of any drug. Bars are the means+s.e.mean of 4 ± 14 experiments. ***P50.001 vs the respective value obtained at pCa 6.5 alone.
2+ sensitization mechanisms in vascular smooth muscleboth receptor agonists and GTP g S activate PKC through the production of diacylglycerol and then increase the sensitivity of the contractile proteins to Ca 2+ in vascular smooth muscle (Lee & Severson, 1994) . This has been supported by the ®nding that the PKC inhibitor H-7 inhibits the enhancement of the Ca 2+ -induced contractions induced by GTP g S and some receptor agonists (Nishimura et al., 1988; Satoh et al., 1994) . By contrast, the present study demonstrated that neither calphostin C nor staurosporine did aect GTP g S-induced Ca 2+ sensitization in b-escin-permeabilized smooth muscle of rabbit mesenteric artery, whereas they completely inhibited PDBuinduced Ca 2+ sensitization. This discrepancy may be related to the selectivity of PKC inhibitors used; H-7 is known to have nonspeci®c actions, especially at high concentrations, such as inhibition of MLC kinase and cyclic nucleotide-dependent kinases (Hidaka et al., 1984) , resulting in nonselective inhibition of smooth muscle contractions. In agreement with our results, Itoh et al. (1994) have reported that PKC 19 ± 36 , a peptide inhibitor of PKC, inhibited the Ca 2+ sensitizing eect of PDBu, but not that of GTP g S in vascular smooth muscle. Furthermore, GTP g S is capable of further potentiating the Ca 2+ -induced contraction even in the presence of saturated concentrations of PDBu Itoh et al., 1994) , suggesting that GTP g S and PDBu induce Ca 2+ sensitization through activation of dierent signaling pathways. It is thus reasonable to conclude that PKC does not contribute to GTP g S-induced Ca 2+ sensitization of smooth muscle of rabbit mesenteric artery. In similar to GTP g S, phenylephrine and histamine enhanced the Ca 2+ -induced contractions without being modi®ed by the PKC inhibitors. While the possibility cannot ruled out that some receptor agonists may generate enough diacylglycerol to activate PKC to a level similar to that activated by phorbol esters and result in Ca 2+ sensitization through the PKC-dependent pathway, our conclusion that PKC has only a minor role, if any, in agonist-induced Ca 2+ sensitization is consistent with the results obtained in PKC-downregulated rat aorta (Hori et al., 1993) . Therefore, it seems likely that phenylephrine and histamine also caused Ca 2+ sensitization through a PKCindependent pathway.
In the present study, we showed that the putative tyrosine kinase inhibitors genistein and tyrphostin 25 caused an irreversible and complete inhibition of GTP g S-induced Ca 2+ sensitization. The fact that the same eect was produced by the two structurally unrelated tyrosine kinase inhibitors, which act through dierent mechanisms (Akiyama et al., 1987; Gazit et al., 1989) , con®rms that the inhibition was the result of a speci®c action on tyrosine kinases. This conclusion is supported by the ®nding that the inactive genistein analogue daidzein was ineective in inhibiting the Ca 2+ sensitizing eect of GTP g S. Furthermore, the lack of eect on the Ca 2+ -induced contraction and PDBu-induced Ca 2+ sensitization provides evidence that the inhibitors did not produce their eects nonspeci®cally by inhibiting the contractile process directly. Hence, we suggest that tyrosine kinases play a major role in GTP g S-induced Ca 2+ sensitization of smooth muscle of rabbit mesenteric artery.
In view of the above-mentioned conclusion that rho p21 is predominantly involved in GTP g S-induced Ca 2+ sensitization, we assume that rho p21 may activate a tyrosine kinase cascade in vascular smooth muscle cells which could eventually lead to Ca 2+ sensitization of contractile apparatus. There is evidence from a number of cell types that rho p21 mediates tyrosine phosphorylation of multiple substrates including p125 focal adhesion kinase and paxillin (Seckl et al., 1995; Imamura et al., 1996) . Paxillin is a regulatory component of the complex of cytoskeletal proteins that link the actin cytoskeleton to the plasma membrane. Wang et al. (1996) have demonstrated that an increase in the tyrosine phosphorylation of paxillin is associated with active force development in canine tracheal smooth muscle. They have also observed that MLC phosphorylation could be reduced by genistein in proportion to the reduction in force in smooth muscle. These ®ndings suggest that phosphotyrosine-containing proteins may be involved in signal transduction processes for the regulation of force development in smooth muscle. It is therefore likely that the large part of GTP g S-induced Ca 2+ sensitization in vascular smooth muscle is closely related to rho p21-mediated protein tyrosine phosphorylation.
The present study revealed that the tyrosine kinase inhibitors irreversibly and completely inhibited Ca 2+ sensitization induced by phenylephrine and histamine. This suggests that the protein tyrosine phosphorylation process may also be a key step of signal transduction in Ca 2+ sensitization caused by these receptor agonists in vascular smooth muscle. Indeed, a recent study has demonstrated that histamine increases phosphorylation of a number of proteins on tyrosine residues in swine carotid artery (Rembold & Weaver, 1997) . However, whether heterotrimeric G protein-coupled receptors are directly or indirectly linked to tyrosine kinases is not known. The lack of eect of C3 pretreatment on agonist-induced Ca 2+ sensitization suggests that rho p21 is not a component of the signal transduction pathway linking heterotrimeric G proteincoupled receptors with tyrosine phosphorylation, but other small G proteins may work as a link between them. The precise mechanism(s) linking the receptors with tyrosine phosphorylation of the proteins involved in Ca 2+ sensitization of contractile apparatus warrents further investigation.
In conclusion, using b-escin-permeabilized smooth muscle of rabbit mesenteric artery, we demonstrate that protein tyrosine phosphorylation, but not PKC, plays a critical role in both of the Ca 2+ sensitizing eects of GTP g S and receptor agonists. Since rho p21 predominantly mediated the eect of Figure 10 Eect of genistein on phenylephrine-and histamineinduced enhancement of the Ca 2+ contraction in b-escin-skinned smooth muscle of rabbit mesenteric artery. The Ca 2+ sensitizing eects of 1 mM phenylephrine (a) and 10 mM histamine (b) obtained in the simultaneous presence of 10 mM GTP were irreversibly and completely blocked by 100 mM genistein.
2+ sensitization mechanisms in vascular smooth muscleGTP g S, at least anyone of tyrosine kinases involved in the protein phosphorylation could act in the downstream of rho p21, thereby leading to GTP g S-induced Ca 2+ sensitization. On the other hand, rho p21 does not appear to lie in the upstream of tyrosine phosphorylation associated with receptor agonist activation.
